Immediate Impact

1 by Nobel laureates 3 from Science/Nature 62 standout
Sub-graph 1 of 23

Citing Papers

Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
2025 Standout
Crohn's disease
2024 Standout
2 intermediate papers

Works of Diana Luca being referenced

EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) Study Identifies Fecal Calprotectin, Serum MMP9, and Serum IL-22 as a Novel Combination of Biomarkers for Crohn's Disease Activity: Role of Cross-Sectional Imaging
2013
Safety, pharmacokinetics, and biologic activity of pateclizumab, a novel monoclonal antibody targeting lymphotoxin α: results of a phase I randomized, placebo-controlled trial
2012

Author Peers

Author Last Decade Papers Cites
Diana Luca 100 129 194 107 23 442
Earl J. Kasdon 195 149 100 74 24 493
T. Fukuda 99 148 157 80 33 510
Sándor Dósa 106 110 51 62 21 424
Derek Roskell 211 113 41 85 27 452
Takahiko Toyonaga 100 222 240 44 30 420
Mary G. Beale 50 105 118 18 15 437
Konstantinos Oikonomou 114 158 214 20 21 460
I Janatková 62 63 64 45 32 401
Harshna Patel 81 88 65 53 12 401
Alan V. Richman 63 104 28 78 29 463

All Works

Loading papers...

Rankless by CCL
2026